EMA panel for conditional OK to Clovis's ovarian cancer drug
(Reuters) - A panel of European Medicines Agency (EMA) has recommended granting conditional marketing approval to Clovis Oncology's drug for ovarian cancer, citing anti-tumour activity.
from Reuters: Health News http://reut.rs/2uck0If
http://bit.ly/2zwRqiM